Sequential Proteomic and N-Glycoproteomic Analyses of Bronchoalveolar Lavage Fluids for Potential Biomarker Discovery of Lung Adenocarcinoma
- 27 January 2025
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 24 (2) , 786-794
Abstract
Lung adenocarcinoma (LUAD) is the most common histological subtype of nonsmall-cell lung cancer. Herein, a multiomics method, which combined proteomic and N-glycoproteomic analyses, was developed to analyze the normal and cancerous bronchoalveolar lavage fluids (BALFs) from six LUAD patients to identify potential biomarkers of LUAD. The data-independent acquisition proteomic analysis was first used to analyze BALFs, which identified 59 differentially expressed proteins (DEPs). The bioinformatic analyses of 59 DEPs have shown that a potential marker protein, beta-1,4-galactosyltransferase 1 (B4GALT1), was consistently downregulated in all cancerous lung lobes (CLLs). As the downregulation of B4GALT1 may indicate changes in protein N-glycosylation, site-specific N-glycoproteome analysis of BALFs from the normal lung lobes (NLLs) and CLLs was further performed by using a fully automated glycopeptide enrichment and separation system. Comparing the glycan structures containing free GlcNAc in BALFs between NLLs and CLLs qualitatively, the percentage of unique glycan structure for free GlcNAc existing only in NLLs was 52.8%, which was significantly higher than the 46.3% existing only in CLLs. Furthermore, the sequential proteomic and N-glycoproteomic analyses allowed us to identify a panel of functionally related potential biomarkers consisting of one protein (B4GALT1) and four glycoproteins (NFKB1, F2, LTF, and DLD).Keywords
Funding Information
- National Key Research and Development Program of China (2023YFC3304203)
- K. C. Wong Magna Fund in Ningbo University (xkzwl1507)
- National Natural Science Foundation of China (U20A20121)
- Natural Science Foundation of Zhejiang Province (LGC22B050002)
- Zhejiang Engineering Research Center of Advanced Mass Spectrometry and Clinical Application (zyk2207)
- Yangtze River Delta Science and Technology Innovation Community Joint Research Project (2023CSJGG1800)
This publication has 35 references indexed in Scilit:
- A Fully Automated Online Enrichment and Separation System for Highly Reproducible and In-Depth Analysis of Intact GlycopeptideAnalytical Chemistry, 2024
- Site-Specific Analysis of Core and Antenna Fucosylation on Serum GlycoproteinsAnalytical Chemistry, 2024
- Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics modelEuropean Radiology, 2023
- In-Depth Mass Spectrometry Analysis Reveals the Plasma Proteomic and N-Glycoproteomic Impact of an Amish-Enriched Cardioprotective Variant in B4GALT1Molecular & Cellular Proteomics, 2023
- Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110Cancer Letters, 2021
- The promises and challenges of early non‐small cell lung cancer detection: patient perceptions, low‐dose CT screening, bronchoscopy and biomarkersMolecular Oncology, 2020
- Detection of 1 zmol injection of angiotensin using capillary zone electrophoresis coupled to a Q-Exactive HF mass spectrometer with an electrokinetically pumped sheath-flow electrospray interfaceTalanta, 2019
- In‐Depth Proteomic Analysis of Human Bronchoalveolar Lavage Fluid toward the Biomarker Discovery for Lung CancersProteomics – Clinical Applications, 2019
- Glycoproteomics using fluid‐based specimens in the discovery of lung cancer protein biomarkers: Promise and challengeProteomics – Clinical Applications, 2012
- Proteome analysis of bronchoalveolar lavage in lung diseasesProteomics, 2006